2018 International Congress of Diabetes and Metabolism

S5 Obesity, browning and whitening : Adipocyte lipotoxicity “friend or foe?	09:00~10:40 / Friday 12 October Emerald hall A Chairman: Ki-Up Lee, Barbara B. Kahn	Overview
Organizer: Eun Hee Koh This session entitled with 'obesity, browning and whitening' is basic session. Metabolically active brown adipose tissue playing an important role in metabolic control and body weight regulation exists in humans. Recently, many studies demonstrate that subcutaneous white adipose tissue can metabolize stored energy in brown-like ("beige" or "browing") adipocytes to contribute to overall energy expenditure. In this session, a new molecular mechanism and pathophysiology of white-to-brown adipocytes in the obesity development, will be presented and discussed. This session will present a new therapeutic strategy for managing obesity and obesity-related metabolic diseases.
Zoltan P. Arany University of Pennsylvania, USA	S5-1 The dark side of PGC-1: from dark skin to dark fat
Aimin Xu University of Hong Kong, Hong Kong	S5-2 Crosstalk between adipokines and hepatokines in the maintenance of metabolic homeostasis and cardiovascular health
Eun Hee Koh University of Ulsan, Korea	S5-3 Mitophagy is necessary for the maintenance of brown fat function.
Jae Bum Kim Seoul National University, Korea	S5-4 Novel roles of lipid droplet binding proteins in fat tissue

S10 NAFLD and diabetes : Organ crosstalk in obesity and NAFLD	13:20~15:20 / Friday 12 October Emerald hall A Chairman: Hong Kyu Lee, Sung Hee Ihm	Overview
Organizers: Yong Ho Lee, Keun-Gyu Park This session entitled with 'NAFLD and diabetes' is basic and translational session and designed to provide a place for basic researchers and clinicians to understand the novel pathophysiology and potential therapeutic targets for obesity and NAFLD. In this session, various mechanisms including gut-liver or muscle-liver axis, immunology and hepatic FXR/SHP pathways will be presented and discussed by outstanding international speakers. It will also cover the repertoire of inter-organ communications and aging that have an influence on metabolic diseases.
Sung Soon Fang Yonsei University, Korea	S10-2 Bile acid signaling in the gut: novel therapeutic strategy for type I and II diabetes
Sang Geon Kim Seoul National University, Korea	S10-3 Gα13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism
David Moore Baylor University, USA	S10-4 Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice

ICDM 2018